Gastroenterology
Volume 129, Issue 3 , Pages 894-901 , September 2005

Efficacy and Safety of Ursodeoxycholic Acid Versus Cholestyramine in Intrahepatic Cholestasis of Pregnancy

  • Jurate Kondrackiene

      Affiliations

    • Department of Gastroenterology, Kaunas University of Medicine, Kaunas, Lithuania
    • Corresponding Author InformationAddress requests for reprints to: Jurate Kondrackiene, MD, PhD, Department of Gastroenterology, Kaunas University of Medicine, Eiveniu Street 2, 50009 Kaunas, Lithuania.fax: (37) 0 37 326508.
    • ,
  • Ulrich Beuers

      Affiliations

    • Department of Medicine II, Klinikum Grosshadern, University of Munich, Munich, Germany
    • ,
  • Limas Kupcinskas

      Affiliations

    • Department of Gastroenterology, Kaunas University of Medicine, Kaunas, Lithuania

Received 22 December 2004 ,Accepted 26 May 2005.

References 

  1. Reyes H , Sjovall J . Bile acids and progesterone metabolites in intrahepatic cholestasis of pregnancy . Ann Med . 2000;32:94–106
  2. Reyes H . Review: intrahepatic cholestasis. A puzzling disorder of pregnancy . Gastoenterol Hepatol . 1997;12:211–216
  3. Lammert F , Marschall HU , Glantz A , Matern S . Intrahepatic cholestasis of pregnancy (molecular pathogenesis, diagnosis and management) . J Hepatol . 2000;33:1012–1021
  4. Bacq Y , Sape T , Bréchot MC , Pierre F , Fignon A , Dubois F . Intrahepatic cholestasis of pregnancy (a French prospective study) . Hepatology . 1997;26:358–364
  5. Rioseco AJ, Ivankovic MB, Manzur A, Hamed F, Kato SR, Parer JT, et al. Intrahepatic cholestasis of pregnancy (a retrospective case-control study of perinatal outcome) . Am J Obstet Gynecol . 1994;170:890–895
  6. Alsulyman OM , Ouzounian JG , Ames-Castro M , Goodwin TM . Intrahepatic cholestasis of pregnancy (perinatal outcome associated with expectant management) . Am J Obstet Gynecol . 1996;175:957–960
  7. Fisk NM , Bye WB , Storey GN . Maternal features of obstetric cholestasis (20 years experience at King George V Hospital) . Aust N Z J Obstet Gynaecol . 1988;28:172–176
  8. Meng LJ , Reyes H , Palma J , Hernandez J , Ribalta J , Sjovall J . Effects of ursodeoxycholic acid on conjugated bile acids and progesterone metabolites in serum and urine of patients with intrahepatic cholestasis of pregnancy . J Hepatol . 1997;27:1029–1040
  9. Meng LJ , Reyes H , Palma J , Hernandez J , Ribalta J , Sjovall J . Progesterone metabolism in normal human pregnancy and in patients with intrahepatic cholestasis of pregnancy . In:  Reyes HB ,  Leuschner U ,  Arias IM editor. Pregnancy, sex hormones and the liver . Dordrecht: Kluver Academic; 1996;p. 91–100
  10. Jacquemin E . Role of multidrug resistance 3 deficiency in pediatric and adult liver disease (one gene for three diseases) . Semin Liver Dis . 2001;21:551–562
  11. Jacquemin E, De Vree JM, Cresteil D, Sokal EM, Sturm E, Dumont M, et al. The wide spectrum of multidrug resistance 3 deficiency (from neonatal cholestasis to cirrhosis of adulthood) . Gastroenterology . 2001;120:1448–1458
  12. Jacquemin E , Cresteil D , Manouvrier S , Boute O , Hadchouel M . Heterozygous non-sense mutation of the MDR3 gene in familial intrahepatic cholestasis of pregnancy . Lancet . 1999;353:210–211
  13. Pauli-Magnus C, Lang T, Meier Y, Zodan-Marin T, Jung D, Breymann C, et al  Sequence analysis of bile salt export pump (ABCB11) and multidrug resistance p-glycoprotein 3 (ABCB4, MDR3) in patients with intrahepatic cholestasis of pregnancy . Pharmacogenetics . 2004;14:91–102
  14. Pauli-Magnus C , Meier P . Pharmacogenetics of hepatocellular transporters . Pharmacogenetics . 2003;13:189–198
  15. Savander M, Ropponen A, Avela K, Weerasekera N, Cormand B, Hirvioja M-L, et al  Genetic evidence of heterogeneity in intrahepatic cholestasis of pregnancy . Gut . 2003;52:1025–1029
  16. Jenkins JK , Boothby LA . Treatment of itching associated with intrahepatic cholestasis of pregnancy . Ann Pharmacother . 2002;36:1462–1465
  17. Burrows RF , Clavisi O , Burrows E . Interventions for treating cholestasis in pregnancy . Cochrane Database Syst Rev . 2001;CD000493
  18. Sadler LC , Lane M , North R . Severe fetal intracranial haemorrhage during treatment with cholestyramine for intrahepatic cholestasis of pregnancy . Br J Obstet Gynaecol . 1995;102:169–170
  19. Stellaard F , Sackmann M , Sauerbruch T , Paumgartner G . Simultaneous determination of cholic acid and chenodeoxycholic acid pool sizes and fractional turnover rates in human serum using 13C-labeled bile acids . J Lipid Res . 1984;25:1313–1319
  20. Paumgartner G , Beuers U . Ursodeoxycholic acid in cholestatic liver disease (mechanisms of action and therapeutic use revisited) . Hepatology . 2002;36:525–531
  21. Beuers U , Boyer JL , Paumgartner G . Ursodeoxycholic acid in cholestasis (potential mechanisms of action and therapeutic applications) . Hepatology . 1998;28:1449–1453
  22. Lazaridis KN , Gores GJ , Lindor KD . Ursodeoxycholic acid mechanisms of action and clinical use in hepatobiliary disorders . J Hepatol . 2001;35:134–146
  23. Trauner M , Graziadei IW . Review article (mechanisms of action and therapeutic applications of ursodeoxycholic acid in chronic liver diseases) . Aliment Pharmacol Ther . 1999;13:979–996
  24. Fickert P, Zollner G, Fushsbichler A, Stumptner C, Pojer C, Zenz R, et al  Effects of ursodeoxycholic and cholic acid feeding on hepatocellular transporter expression in mouse liver . Gastroenterology . 2001;121:170–183
  25. Palma J, Reyes H, Ribalta J, Hernandez I, Sandoval L, Almuna R, et al  Ursodeoxycholic acid in the treatment of cholestasis of pregnancy (a randomized, double-blind study controlled with placebo) . J Hepatol . 1997;27:1022–1028
  26. Palma J , Reyes H , Ribalta J , Iglesias J , Gonzalez MC , Hernandez I , et al.   Effects of ursodeoxycholic acid in patients with intrahepatic cholestasis of pregnancy . Hepatology . 1992;15:1043–1047
  27. Beuers U, Bilzer M, Chittattu A, Kullak-Ublick GA, Keppler D, Paumgartner G, et al. Tauroursodeoxycholic acid inserts the apical conjugate export pump, Mrp2, into canalicular membranes and stimulates organic anion secretion by protein kinase C-dependent mechanisms in cholestatic rat liver . Hepatology . 2001;33:1206–1216
  28. Rubin RA , Kowalski TE , Khandelwal M , Malet PF . Ursodiol for hepatobiliary disorders . Ann Intern Med . 1994;121:207–218
  29. Berkane N , Cocheton J- J , Merviel P , Wolf C , Lefevre G , Uzan S . Ursodeoxycholic acid in intrahepatic cholestasis of pregnancy . Acta Obstet Gynecol Scand . 2000;79:941–946
  30. Angulo P . Use of ursodeoxycholic acid in patients with liver disease . Curr Gastroenterol Rep . 2002;4:37–44
  31. Floreani A , Paternoster D , Melis A , Grella PV . S-adenosylmethionine versus ursodeoxycholic acid in the treatment of intrahepatic cholestasis of pregnancy (preliminary results of a controlled trial) . Eur J Obstet Gynecol Reprod Biol . 1996;67:109–113
  32. Nicastri PL , Diaferia A , Tartagni M , Loizzi P , Fanelli M . Randomized placebo-controlled trial of ursodeoxycholic acid and S-adenosylmethionine in the treatment of intrahepatic cholestasis of pregnancy . Br J Obstet Gynaecol . 1998;105:1205–1207
  33. Mazzella G, Rizzo N, Azzaroli F, Simoni P, Bovicelli L, Miracolo A, et al  Ursodeoxycholic acid administration in patients with cholestasis of pregnancy (effects on primary bile acids in babies and mothers) . Hepatology . 2001;33:504–508
  34. Mazzella G , Rizzo N , Salzetta A , Iampieri R , Bovicelli L , Roda E . Management of intrahepatic cholestasis in pregnancy . Lancet . 1991;338:1594–1595
  35. Hofmann AF . Pharmacology of ursodeoxycholic acid, an enterohepatic drug . Scand J Gastroenterol . 1994;29:1–15
  36. Milkievicz P , Elias E , Williamson C , Weaver J . Obstetric cholestasis . BMJ . 2002;324:123–124
  37. Milkievicz P , Gallagher R , Eggington E , Kilby M , Weawer JB , Elias E . Obstetric cholestasis with elevated GGT (incidence, presentation and treatment) . Hepatology . 2001;34:A364
  38. Brites D , Poeiras J , Rodrigues C . Intrahepatic cholestasis in pregnancy. Its etiopathogenesis, prognosis and therapy . Acta Med Port . 1994;7:181–188
  39. Brites D , Rodrigues CM . Elevated levels of bile acids in colostrum of patients with cholestasis of pregnancy are decreased following ursodeoxycholic acid therapy . J Hepatol . 1998;29:743–751
  40. Brites D , Rodrigues CM , van-Zeller H , Brito A , Silva R . Relevance of serum bile acid profile in the diagnosis of intrahepatic cholestasis of pregnancy in an high incidence area (Portugal) . Eur J Obstet Gynecol Reprod Biol . 1998;80:318
  41. Brites D , Rodriques CMP , Oliveira N , Cardoso MC , Graca LM . Correction of maternal serum bile acid profile during ursodeoxycholic acid therapy in cholestasis of pregnancy . J. Hepatol . 1998;28:91–98
  42. Macias RIR, Pascual MJ, Bravo A, Alcalde MP, Larena MG, Pierre MVS, et al. Effect of maternal cholestasis on bile acid transfer across the rat placenta-maternal liver tandem . Hepatology . 2000;4:975–983
  43. Serrano MA , Brites D , Larena MG , et al.   Beneficial effect of ursodeoxycholic acid on alterations induced by cholestasis of pregnancy in bile acid transport across the human placenta . J Hepatol . 1998;28:829–839
  44. Glantz A , Marschall H-U , Mattsson L-A . Intrahepatic cholestasis of pregnancy (relationships between bile acid levels and fetal complication rates) . Hepatology . 2004;4:467–474
  45. Sepulveda WH , Gonzalez C , Cruz MA , Rudolph MI . Vasoconstrictive effect of bile acids on isolated human placental chorionic veins . Eur J Obstet Gynecol Reprod Biol . 1991;42:211–215
  46. Simpson LL . Maternal medical disease (risk of antepartum fetal death) . Semin Perinatol . 2002;26:42–50

 Supported in part by a grant from the Science Foundation of Kaunas University of Medicine and by Dr. Falk, Pharma GmbH, Freiburg, Germany.

PII: S0016-5085(05)01121-2

doi: 10.1053/j.gastro.2005.06.019

Gastroenterology
Volume 129, Issue 3 , Pages 894-901 , September 2005

Article Tools

* Image Usage & Resolution